We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Injured Kidneys Are Viable Candidates for Transplantation

By HospiMedica International staff writers
Posted on 24 Mar 2015
Injured kidneys from deceased donors may be more viable than previously thought, according to a new study.

Researchers at Yale University (New Haven, CT, USA) conducted a multicenter study involving 1,632 patients to determine associations between acute kidney injury (AKI), kidney discard rates, delayed graft function (DGF), and estimated glomerular filtration rate (eGFR) in the short term, as well as six months after transplantation. More...
As they anticipated, the researchers found an association between AKI and organ discard. They also found that injured kidneys were associated with DGF and a need for continued dialysis support in the first week after transplantation.

The study did not find, however, a link between deceased-donor AKI and poor kidney transplant function six months later. They also found significant favorable interaction between donor AKI and DGF, so that six-month eGFR was progressively better for DGF kidneys with increasing donor AKI. In fact, six-month transplant function was worst for those with DGF who had received a donated kidney with no apparent injury. The study was published in the March 2015 issue of the American Journal of Transplantation.

“Though that result seemed counterintuitive, organs acutely injured in the donor might develop ischemic preconditioning, a mechanism that could protect the organs from the effects of subsequent injury,” suggested lead author Isaac Hall, MD. “Another possible explanation is that the successfully transplanted kidneys with AKI were of otherwise higher quality than the rejected kidneys with AKI, though the study did adjust for many important variables like donor age and comorbidity.”

“The waiting list has grown to over 100,000 patients as thousands more people are wait-listed each year than actually receive a transplant, and more than 5,000 people die each year while waiting for a kidney,” added senior author Chirag Parikh, MD. “Even if it only means a few dozen more kidney transplants each year, those are patients who would come off of the waiting list for transplants sooner and have much better survival than continuing on dialysis in hopes of seemingly higher-quality kidney offers, which may never come in time.”

Donated kidneys with AKI are often discarded for fear of poor outcomes, such as delayed function and even premature kidney transplant failure.

Related Links:

Yale University



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.